ClinicalTrials.gg
Not yet recruitingNCT07839169Updated Sep 24, 2026

Effects of SIS Therapy in Individuals With Chronic Nonspecific Low Back Pain

An interventional study of SIS Therapy and Conventional Physiotherapy in Chronic Nonspecific Low Back Pain, sponsored by Pamukkale University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-24.

Sponsored by Pamukkale University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 15 studies in Pain by Pamukkale University — 3 open to participants now, 3 under way, none of them phase 3. Pain · Pamukkale University.

Planned enrollment
6th of 15
60 · median 52
Started
2026
with 2 others
No phase
14 of 15
3 open now
Registered
15th of 15
by date

Among the 15 studies in Pain by Pamukkale University, this one is the 6th largest by planned enrollment, is one of 3 that started in 2026, is one of 14 with no phase, and was the 15th registered.

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

Browse Pain studies →

Open to participants now

3 of the 15 studies in Pain by Pamukkale University are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Pain by Pamukkale University, or all of them as a file.
02

Study summary

Brief Summary - buraya yapıştırın

Chronic nonspecific low back pain is a common condition that can cause pain, limitations in daily activities, and reduced quality of life. Exercise and conventional physiotherapy are commonly used to manage chronic low back pain. SIS Therapy is a physiotherapy approach intended to reduce pain and improve movement and function.

The aim of this randomized controlled trial is to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare these effects with conventional physiotherapy.

Participants will be randomly assigned to one of two groups. The SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. The conventional physiotherapy group will receive a program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice a week for four weeks, for a total of eight sessions, and both groups will receive the same home exercise program.

Participants will be evaluated before and after the four-week treatment period. The assessments will examine changes in pain intensity, lumbar mobility, and back extensor muscle endurance.

Read the detailed description

This study is a prospective, assessor-blinded, two-arm, parallel-group randomized controlled trial designed to investigate the effects of SIS Therapy in individuals with chronic nonspecific low back pain and to compare its effects with conventional physiotherapy.

Individuals aged 18-65 years with chronic nonspecific low back pain lasting for at least three months will be screened for eligibility. Individuals with a Visual Analog Scale (VAS) pain intensity score of 4 or higher, who are able to walk independently and who voluntarily agree to participate in the study by providing written informed consent will be included.

After enrollment, participants will be randomly allocated to one of two intervention groups in a 1:1 ratio using a computer-generated randomization sequence. Allocation concealment will be achieved using sequentially numbered, opaque, sealed envelopes prepared according to the randomization sequence by a researcher independent of the study. The researcher responsible for outcome assessments will be blinded to group allocation.

Participants allocated to the SIS Therapy group will receive SIS Therapy together with a standard exercise program consisting of lumbar stabilization and stretching exercises. Participants allocated to the conventional physiotherapy group will receive a conventional physiotherapy program consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Both groups will receive treatment twice per week for four weeks, resulting in a total of eight treatment sessions. In addition, the same home exercise program will be provided to participants in both groups.

Outcome assessments will be performed at baseline before the intervention and after completion of the four-week intervention period by the same assessor under standardized conditions.

Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will indicate the intensity of their current low back pain on a 10-cm horizontal line ranging from 0, representing no pain, to 10, representing the worst or unbearable pain.

Pressure pain threshold (PPT) will also be assessed to provide a quantitative measure of mechanical pain sensitivity. A pressure algometer will be applied perpendicular to standardized measurement sites in the lumbar paraspinal region, and pressure will be gradually increased. Participants will be instructed to indicate the moment when the sensation of pressure first becomes painful. The pressure value at this point will be recorded as the pressure pain threshold. Measurements will be repeated at the predetermined sites, and the mean value will be used for analysis. Higher PPT values will indicate a higher pressure pain threshold and lower mechanical pain sensitivity.

Lumbar flexion mobility will be evaluated using the Modified Modified Schober Test (MMST). The participant will stand in an upright position, and standardized anatomical landmarks will be identified. The change in distance between the marked points during maximal forward trunk flexion will be recorded as an indicator of lumbar flexion mobility.

Static endurance of the lumbar extensor muscles will be evaluated using the Sorensen Back Extensor Endurance Test. During the test, the pelvis and lower extremities will be stabilized while the participant maintains the upper trunk in a horizontal position for as long as possible. The duration for which the position can be maintained will be recorded in seconds, with longer durations indicating greater back extensor endurance.

Functional disability related to low back pain will be evaluated using the Oswestry Disability Index (ODI). The ODI will be used to determine the degree to which low back pain affects participants' daily activities and functional status.

A total of 60 participants are planned to be enrolled in the study, with 30 participants allocated to each group. The sample size was determined based on an alpha level of 0.05, statistical power of 80%, and an anticipated effect size of Cohen's d = 0.80. The target sample size was increased to account for an anticipated dropout rate of approximately 15%.

The primary objective of the study is to determine whether SIS Therapy, when combined with an exercise program, produces changes in pain intensity compared with conventional physiotherapy in individuals with chronic nonspecific low back pain. Secondary objectives include investigating changes in pressure pain threshold, functional disability, lumbar mobility, and back extensor muscle endurance following the intervention.

03

Conditions studied

  • Chronic Nonspecific Low Back Pain

Browse trials for

Keywords

  • Exercise Therapy
  • Rehabilitation
  • Physiotherapy
  • Physical Therapy
  • Pain
  • Chronic Nonspecific Low Back Pain
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Inclusion Criteria:

  • Inclusion Criteria:

Aged between 18 and 65 years Having chronic nonspecific low back pain for at least 3 months Having a pain intensity of 4 or higher on the Visual Analog Scale (VAS) Being able to walk independently Volunteering to participate in the study and providing written

Exclusion Criteria:

History of lumbar spine surgery Severe neurological deficit or radiculopathy associated with disc herniation Presence of vertebral fracture, tumor, infection, or inflammatory rheumatic disease Pregnancy History of Having received physiotherapy for the lumbar region within the previous 3 months Cognitive or communication problems that may prevent compliance with the assessments

-

Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    SIS Therapy Group

    Participants in this group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.

    Other: SIS Therapy

  • Active comparator
    Conventional Physiotherapy Group

    Participants in this group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. The intervention will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the SIS Therapy group.

    Other: Conventional Physiotherapy

Interventions

  • OtherSIS Therapy

    Participants assigned to the experimental group will receive SIS Therapy in addition to a standard exercise program consisting of lumbar stabilization and stretching exercises. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive a home exercise program.

  • OtherConventional Physiotherapy

    Participants assigned to the active comparator group will receive conventional physiotherapy consisting of heat application, transcutaneous electrical nerve stimulation (TENS), therapeutic ultrasound, and therapeutic exercise. Treatment will be administered twice weekly for four weeks, for a total of eight treatment sessions. Participants will also receive the same home exercise program provided to the experimental group.

06

What researchers measure

Primary outcomes

  1. Change in Pain Intensity Assessed by the Visual Analog Scale (VAS)

    Pain intensity will be assessed using the Visual Analog Scale (VAS). Participants will rate their current low back pain on a 10-cm horizontal scale ranging from 0 (no pain) to 10 (unbearable pain). Higher scores indicate greater pain intensity. Change in VAS score from baseline to the end of the 4-week intervention will be evaluated.

    Time frame: Baseline and immediately after the 4-week intervention

  2. Change in Pressure Pain Threshold Assessed by Pressure Algometry

    Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become painful. The pressure value at this point will be recorded as the PPT. Higher PPT values indicate lower mechanical pain sensitivity.

    Time frame: Pressure pain threshold (PPT) will be assessed using a pressure algometer at standardized measurement sites in the lumbar paraspinal region. Pressure will be gradually increased until the participant first reports that the pressure sensation has become p

Secondary outcomes

  1. Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)

    Change in Functional Disability Assessed by the Oswestry Disability Index (ODI)

    Time frame: Baseline and immediately after the 4-week intervention

  2. Change in Lumbar Flexion Mobility Assessed by the Modified Modified Schober Test (MMST)

    Lumbar flexion mobility will be assessed using the Modified Modified Schober Test (MMST). The change in distance between standardized anatomical landmarks during maximal forward trunk flexion will be recorded in centimeters. A greater increase in distance indicates greater lumbar flexion mobility.

    Time frame: Baseline and immediately after the 4-week intervention

  3. Change in Back Extensor Muscle Endurance Assessed by the Sorensen Test

    Back extensor muscle endurance will be assessed using the Sorensen Back Extensor Endurance Test. The duration for which the participant can maintain the standardized horizontal trunk position will be recorded in seconds. Longer durations indicate greater back extensor muscle endurance.

    Time frame: Baseline and immediately after the 4-week intervention

07

Study locations

1 site
  • Aydın Şehir Hastanesi
    Aydin, Aydın 09100, Turkey (Türkiye)
08

References and documents

Publications

  • George SZ, Fritz JM, Silfies SP, Schneider MJ, Beneciuk JM, Lentz TA, Gilliam JR, Hendren S, Norman KS. Interventions for the Management of Acute and Chronic Low Back Pain: Revision 2021. J Orthop Sports Phys Ther. 2021 Nov;51(11):CPG1-CPG60. doi: 10.2519/jospt.2021.0304. PubMed 34719942 ↗
  • Hartvigsen J, Hancock MJ, Kongsted A, Louw Q, Ferreira ML, Genevay S, Hoy D, Karppinen J, Pransky G, Sieper J, Smeets RJ, Underwood M; Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018 Jun 9;391(10137):2356-2367. doi: 10.1016/S0140-6736(18)30480-X. Epub 2018 Mar 21. PubMed 29573870 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared with other researchers. Participant data will be coded and stored securely, with access restricted to the research team. The data will be used solely for the purposes of this study and the reporting of its scientific results.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 18, 2026
First posted
Sep 24, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Dec 30, 2026
CompletionEst.
Apr 30, 2027
Last update
Sep 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07839169
Responsible party
Ayşenur Yılmaz (Assistant Professor, Burdur Mehmet Akif Ersoy University) — Principal investigator
First posted
Sep 24, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 30, 2026 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Sep 24, 2026

Study contacts

aysenur yılmaz, Assistant Professor, PT,PhD
Contact
aysenuryilmaz@mehmetakif.edu.tr
05432833819

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion